Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Mar 28;38:137. doi: 10.1186/s13046-019-1138-7

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 1 — Overexpression of TRIM44 positively correlates with poor prognosis of melanoma patients. a, TRIM44 mRNA levels in different cancers were analyzed by GEPIA. b, TRIM44 mRNA levels in 20 matched pairs of melanoma and peritumoral tissues quantified by qRT-PCR. c, Representative bands of TRIM44 protein levels in 20 matched pairs of melanoma and peritumoral tissues. d, Representative images of TMA stained with H&E and immunohistochemistry for TRIM44. e, TRIM44 expression levels in melanoma and peritumoral tissues analyzed by relative IOD value. Overall survival and recurrence analyses of 197 melanoma patients according to TRIM44 expression. ***p < 0.001, ****p < 0.0001. T, tumor; P, peritumor